MLPA tests, =ANSR for NIPD of trisomy), and identify diseases using DNA microarray= and targeted Next-Gen sequencing. Earlier this year, I re=eived the IFCC Award for Significant Contributions in Molecular Diagn=stics. I have been collaborating with Dr. Linnie Golightly of our Center for =lobal Health/Infectious Disease Division for the past